Home > Cashflow Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
AD     Remove this Ad

AUROBINDO PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹120 Cr₹800 Cr₹1,814 Cr₹-2,969 Cr₹-1,365 Cr

What is the latest Cash Flow from Financing Activities ratio of AUROBINDO PHARMA ?

The latest Cash Flow from Financing Activities ratio of AUROBINDO PHARMA is ₹120 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹120 Cr
Mar2024₹800 Cr
Mar2023₹1,814 Cr
Mar2022₹-2,969 Cr
Mar2021₹-1,365 Cr

How is Cash Flow from Financing Activities of AUROBINDO PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹120 Cr
-85.04
Mar2024 ₹800 Cr
-55.89
Mar2023 ₹1,814 Cr
Positive
Mar2022 ₹-2,969 Cr
Negative
Mar2021 ₹-1,365 Cr -

Compare Cash Flow from Financing Activities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹69,182.0 Cr 1.4% -3.6% 3.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

1.4%

-3.6%

3.5%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses